Immunogenetic Risks of Anti-Cyclical Citrullinated Peptide Antibodies in a North American Native Population with Rheumatoid Arthritis and Their First-degree Relatives

Hani El‐Gabalawy, David Robinson, Donna Hart, Brenda Elias, Janet Markland, Christine Peschken, Irene Smolik, GABRIELA MONTES-ALDANA, Marlis L. Schroeder, Marvin J. Fritzler,

The Journal of Rheumatology · 2009 · 75 citations · 25 references

DOIFull text

Open access

Abstract

An independent association of the non-SE allele DRB1*0901 with RA was confirmed in this population, and this allele in combination with a SE allele was associated with younger age at disease onset. FDR of RA probands have a higher prevalence of anti-CCP antibodies than more distant relatives and unrelated controls, suggesting a gradient of risk for disease development. Immunogenetic risks may act early in disease pathogenesis at the level of initiation of RA autoantibody formation; however, it is not clear what additional genetic and environmental risks are involved in progression to clinical disease.

References

25